Neuro-Bio is pleased to announce that Susan Greenfield, CEO of the company, will be talking at the OBN BioSeed event on 30th of September. BioSeed Lunchtime Express will take place from 12.00-13.00 and will feature 4 x 7 minutes live presentations from life science companies across all therapy areas, seeking Seed or Series A funding up to £2.5 milion.
To find out more, click the link.